Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMRH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $118,011
Award facts
- Contract value 100% obligated
- $118,010.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $118,010.76 firm fixed-price delivery order (4570739530) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, with an ultimate completion date of February 5, 2026. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense facilities, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications such as epinephrine auto-injectors and naloxone.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring medical supply needs across military healthcare facilities worldwide. The underlying PPV-G GEN V IDC, designated SPE2DR and awarded November 13, 2025, carries a $499,999,999 ceiling value and extends through December 31, 2036, with a 30-month base period and three optional 30-month extension periods. The contract positions DMS Pharmaceutical Group as a critical regional prime vendor contractor capable of fulfilling the specialized pharmaceutical requirements of the federal military medical system globally.
Quick answers
Who was awarded contract SPE2DU26FEMRH?
SPE2DU26FEMRH was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DU26FEMRH worth?
The government has obligated $118,011 on SPE2DU26FEMRH.
Is contract SPE2DU26FEMRH an order under another contract?
Yes. SPE2DU26FEMRH is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMRH competed?
The extent of competition for SPE2DU26FEMRH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award